These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3578929)

  • 21. [Serum levels, dose and response in prolonged treatment with theophylline].
    Otero MJ; Barrueco M; Mariño EL; Gómez F; Domínquez-Gil A
    Med Clin (Barc); 1984 Oct; 83(11):447-9. PubMed ID: 6438413
    [No Abstract]   [Full Text] [Related]  

  • 22. Theophylline, a review.
    Rudolph BM
    J Tenn Med Assoc; 1977 Mar; 70(3):171-4. PubMed ID: 839788
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
    Utama I; Kreukniet J; Meering PG; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bronchodilators].
    Advenier C; Cerrina J; Duroux P
    Sem Hop; 1984 Jan; 60(3):179-93. PubMed ID: 6320443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational theophylline use in older asthmatics.
    Koenig HG; Blake RL
    Geriatrics; 1986 Aug; 41(8):49-55. PubMed ID: 3732808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
    Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
    J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of theophylline concentration in serum and saliva].
    Reinhardt D; Becker B
    Internist (Berl); 1982 Dec; 23(12):725-7. PubMed ID: 6761301
    [No Abstract]   [Full Text] [Related]  

  • 28. The changing role of theophylline in pediatric asthma.
    Stoloff SW
    Am Fam Physician; 1994 Mar; 49(4):839-44. PubMed ID: 8116518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a methylxanthine preparation in the form of a retention enema on pulmonary function and theophylline levels in patients with acute bronchospasm.
    Dorow P; Schenk H; Dougherty C
    Arzneimittelforschung; 1986 Jun; 36(6):974-6. PubMed ID: 3741533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Theophylline in the treatment of childhood asthma].
    Zach M
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):696-703. PubMed ID: 7144760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
    von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on the efficacy of a sustained-release theophylline-based preparation in infants with chronic asthma].
    Bertolani P; Bernini GC; Amarri S; Accorsi P
    Pediatr Med Chir; 1985; 7(5):765-9. PubMed ID: 3837245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian rhythms in theophylline pharmacokinetics and pharmacodynamics in asthmatic children.
    Scott PH; Kramer WG; Smolensky MH; Harrist R
    Br J Clin Pract Suppl; 1984; 35():57-63. PubMed ID: 6433963
    [No Abstract]   [Full Text] [Related]  

  • 35. Diltiazem treatment impairs theophylline elimination in patients with bronchospastic airway disease.
    Soto J; Sacristan JA; Alsar MJ
    Ther Drug Monit; 1994 Feb; 16(1):49-52. PubMed ID: 8160255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous system effects of antiasthma medication--an EEG study.
    Shucard DW; Spector SL; Euwer RL; Cummins KR; Shucard JL; Friedman A
    Ann Allergy; 1985 Mar; 54(3):177-84. PubMed ID: 3977133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages].
    Bodner A; Hens C; Moser C; Oster H
    Arzneimittelforschung; 1998 May; 48(5A):617-24. PubMed ID: 9676355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
    Nieto A; Mazón A; Caballero L; Gil MC
    An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.
    Weinberger MW; Matthay RA; Ginchansky EJ; Chidsey CA; Petty TL
    JAMA; 1976 May; 235(19):2110-3. PubMed ID: 946537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):88-92. PubMed ID: 3957498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.